Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Senior VP from Bayer as Board Member
View:
Post by biorun on Jun 20, 2022 7:40am

Senior VP from Bayer as Board Member

This is the kind of specific move institutional investors will wish to see. 

As he says, Sirona is "a Diamond in the Rough".

Well done Howard.
Comment by Tickel1st on Jun 20, 2022 7:58am
This post has been removed in accordance with Community Policy
Comment by biorun on Jun 20, 2022 8:39am
Note to clarify - it looks like his primary role is a primary advisor to the Board, not a board member himself. Even better to have him working with Sirona as a person who can look into what had been going on, and how best to position the company properly, maybe even with the view to position it for a prime buyout. At some point, Sirona should layout the recommendations, but it looks like he had ...more  
Comment by Transperance on Jun 20, 2022 9:18am
Yes, additional board members with supplementing competences and experiences should absolutely be recruited to the board.    Some of the present board members could also be replaced. There is an urgent need to get an adequate governance top-down in the organisation regardless of listing and potential up-listing. 
Comment by theteddyfactor on Jun 20, 2022 11:05am
Real change would mean , board member, CEO, CFO.. I thing and I might be wrong. An advisor to the board, can be tossed aside as fast as he was hired. I am sure any new mangment  and or board member brought to the table  would of kept the share price synergy positive. No doubt Dr. Wolfgang would be such based on his bio. But as Transperance says, having tnew membesr to to significant ...more  
Comment by biorun on Jun 20, 2022 11:23am
Looks like we only have part of the story here. The give back today may be temporary as some profits taken. The stock is nowhere near done with its rise.
Comment by doonery on Jun 20, 2022 12:18pm
i agree biorun,,,as usual i think you are correct,,in fact I  bought some more at .31,,,I think 40+,by thurs/fri.GLTA,,,
Comment by navajojoe on Oct 25, 2022 3:44pm
This post has been removed in accordance with Community Policy
Comment by doonery on Jun 20, 2022 12:19pm
i agree biorun,,,as usual i think you are correct,,in fact I@ bought some more at .31,,,I think 40+,by thurs/fri.GLTA,,,
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities